A critical role for Pol II CTD phosphorylation in heterochromatic gene activation.

Bur1 CTD code ChIP Ctk1 Euchromatin Fluorescence Microscopy Gene Activation Heat Shock Heterochromatin Histone Code Nucleosomes RNA Polymerase II Sir2/3/4-mediated Silent Chromatin Transcription Yeast

Journal

Gene
ISSN: 1879-0038
Titre abrégé: Gene
Pays: Netherlands
ID NLM: 7706761

Informations de publication

Date de publication:
12 Apr 2024
Historique:
received: 30 12 2023
revised: 27 03 2024
accepted: 11 04 2024
medline: 15 4 2024
pubmed: 15 4 2024
entrez: 14 4 2024
Statut: aheadofprint

Résumé

How gene activation works in heterochromatin, and how the mechanism might differ from the one used in euchromatin, has been largely unexplored. Previous work has shown that in SIR-regulated heterochromatin of Saccharomyces cerevisiae, gene activation occurs in the absence of covalent histone modifications and other alterations of chromatin commonly associated with transcription.Here we demonstrate that such activation occurs in a substantial fraction of cells, consistent with frequent transcriptional bursting, and this raises the possibility that an alternative activation pathway might be used. We address one such possibility, Pol II CTD phosphorylation, and explore this idea using a natural telomere-linked gene, YFR057w, as a model. Unlike covalent histone modifications, we find that Ser2, Ser5 and Ser7 CTD phosphorylated Pol II is prevalent at the drug-induced heterochromatic gene. Particularly enriched relative to the euchromatic state is Ser2 phosphorylation. Consistent with a functional role for Ser2P, YFR057w is negligibly activated in cells deficient in the Ser2 CTD kinases Ctk1 and Bur1 even though the gene is strongly stimulated when it is placed in a euchromatic context. Collectively, our results are consistent with a critical role for Ser2 CTD phosphorylation in driving Pol II recruitment and transcription of a natural heterochromatic gene - an activity that may supplant the need for histone epigenetic modifications.

Identifiants

pubmed: 38615982
pii: S0378-1119(24)00354-8
doi: 10.1016/j.gene.2024.148473
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

148473

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: David S. Gross reports financial support was provided by National Institutes of Health. David S. Gross reports financial support was provided by National Science Foundation Division of Molecular and Cellular Biosciences. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Amoldeep S Kainth (AS)

Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, LA 71130, United States.

Hesheng Zhang (H)

Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, LA 71130, United States.

David S Gross (DS)

Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, LA 71130, United States. Electronic address: david.gross@lsuhs.edu.

Classifications MeSH